The Direct-Physio Trial
Direct Access to Physiotherapy for Acute Low Back Pain: a Pragmatic Pilot Trial
1 other identifier
interventional
600
1 country
1
Brief Summary
Previous research showed that direct access to physiotherapy, and the associated early physiotherapeutic treatment of patients with low back pain (LBP), results in improved clinical outcomes, as well as reduced health-related costs. However, despite these results, the effectiveness of direct access to physiotherapy and its impact on costs has never been investigated in Belgium. Therefore, the goal of this study is to compare the (cost-)effectiveness of direct access to physiotherapy compared to usual care by the general practitioner (GP) for patients with acute LBP. In this study, 600 patients with acute LBP (lasting \>24 hours and \<6 weeks) will be divided into two groups (Dutch-speaking: n=2x150; French-speaking n= 2x150). One group will receive treatment through direct access to the physiotherapist, without prescription by a GP. The other group will follow the traditional care pathway through the GP. Th effects on pain, disability and cost-effectiveness will be analysed using questionnaires obtained before and at the end of treatment, after 3 months, after one and after two years. Primary outcomes include pain and disability. Secondary outcomes include clinical outcomes, beliefs related to LBP, quality of life, patient satisfaction, but also direct health care costs, health care resource use, as well as absenteeism and productivity loss. The results of this study will answer the question whether direct access to physiotherapy is (cost)effective for acute LBP. In the long term, these results might be used to optimize the care pathway in Belgium for patients with acute low back pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable low-back-pain
Started Dec 2022
Typical duration for not_applicable low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2021
CompletedFirst Posted
Study publicly available on registry
January 31, 2022
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedFebruary 28, 2023
February 1, 2023
2 years
December 13, 2021
February 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Changes in pain intensity
Numeric Rating Scale
Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment
Changes in pain location and extent
Pain Diagram of Margolis
Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment
Changes in disability
Oswestry Disability Index
Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment
Secondary Outcomes (5)
Cost-effectiveness of the provided treatment (direct physiotherapy access vs usual care for acute low back pain)
Up to 2 years after enrollment
Changes in beliefs and cognitions related to low back
Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment
Changes in patient satisfaction
Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment
Changes in quality of life
Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment
Amount of / coping with flare-ups during follow-up
Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment
Study Arms (2)
Direct physiotherapy pathway
EXPERIMENTALPeople with acute low back pain will directly go to a physiotherapist, who will treat the patient without prescription of the general practitioner.
Usual care pathway
ACTIVE COMPARATORPeople with low back pain will receive usual care by the general practitioner (with or without referral to physiotherapy).
Interventions
Interventions include physiotherapeutic treatment, without prescription of the general practitioner, for low back pain according to current biopsychosocial national (KCE - Belgium) and international (NICE) guidelines.
Interventions include standard of care by the general practitioner for low back pain according to current biopsychosocial national (KCE - Belgium) and international (NICE) guidelines.
Eligibility Criteria
You may qualify if:
- Patients with non-specific acute LBP defined as (based on Nicol et al. 2020):
- pain between the 12th rib and buttocks
- associated or not with non-dominant leg pain
- looking for LBP care for the first time in case of first episode, OR for the first time for the current episode in case of recurrent or persistent LBP
- lasting \> 24 hours and \< 6 weeks
- with an average pain intensity during the past 24 hours of ≥ 3 on an 11-point Numerical Pain Rating Scale
- with an Oswestry Disability Index score (version 2.1a) of at least 20% (Denteneer et al. 2018).
- Patients aged between 18 and 65 years
You may not qualify if:
- Recent lumbar surgery (\< 1 year)
- Pregnancy
- History of (any) treatment for the current pain episode
- Generalized musculoskeletal pain (based on fibromyalgia criteria) (Galvez-Sánchez and Reyes del Paso 2020).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hasselt Universitylead
- KU Leuvencollaborator
- Universiteit Antwerpencollaborator
- Université Catholique de Louvaincollaborator
- Axxon - the Belgian physiotherapy professional associationcollaborator
- Riziv-Inami - National Institute for the Sickness and Invalidity Insurancecollaborator
Study Sites (1)
REVAL Faculty of Rehabilitation Sciences
Diepenbeek, 3590, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lotte Janssens, PhD
UHasselt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 13, 2021
First Posted
January 31, 2022
Study Start
December 1, 2022
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
February 28, 2023
Record last verified: 2023-02